Market Overview

According to fortune business insights, the global perfusion bioreactors market size was valued at USD 812.4 million in 2025. The market is projected to grow from USD 908.3 million in 2026 to USD 2,216.9 million by 2034, exhibiting a CAGR of 11.80% during the forecast period. North America dominated the perfusion bioreactors market with a market share of 38.1% in 2025.

The analysis shows that top companies are investing more in these systems as biopharmaceutical firms face pressure to enhance productivity and ensure consistent product quality. This trend indicates a strong demand for scalable and automated solutions for biologics, biosimilars, and cell and gene therapies worldwide.

Major Players Profiled in the Market Report:

• Sartorius AG (Germany)
• Danaher Corporation (Cytiva) (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• Repligen Corporation (U.S.)
• Eppendorf SE (Germany)
• PBS Biotech, Inc. (U.S.)
• Getinge AB (Sweden)
• Infors AG (Switzerland)
• Meissner Filtration Products, Inc. (U.S.)

Segments

Recurring Use of Various Consumables to Propel Consumables Segment Growth

Based on product, the market is divided into consumables, instruments, software and services, and others. The consumables segment holds the largest market share owing to the continuous and repeated use of items like sterile media bags, tubing sets, and filters, which are replaced after each production cycle.

Increased Demand for Antibody Therapeutics to Drive Monoclonal Antibody Production Segment Expansion

By application, the market is categorized into monoclonal antibody production, cell therapy manufacturing, vaccine production, and others. The monoclonal antibody production segment is leading the market as these biologics require high-yield mammalian cell culture platforms, and perfusion helps enhance cell density and output.

Strong In-house Biologics Manufacturing to Dominate Pharmaceutical & Biotechnology Companies Segment